Physician

Seo-Hyun Kim, M.D.

According to 2025 Medicare claims, Seo-Hyun Kim, M.D. (NPI: 1710253992) practices hematology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is RUSH UNIVERSITY MEDICAL GROUP (NPI: 1093819542; TIN: 91-1780160) and primary practice location at 60607-3106. Kim is affiliated with the CVS Accountable Care Organization, Inc. (ACO ID: D0061), participating under the REACH model.

Kim's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 221 traditional Medicare patients, billed 720 HCPCS/CPT codes, and received $63,290 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 665 prescription claims across 71 beneficiaries totaling $3,554,719 in drug costs, led by Brukinsa (Zanubrutinib). Open Payments data shows 17 records totaling $17,311. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $18,449 and ending at $63,290. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $8,158 to $3,554,719. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	82	188	$18,449
2019	188	578	$54,258
2020	209	724	$69,160
2021	229	697	$74,606
2022	235	748	$78,512
2023	184	470	$49,203
2024	221	720	$63,290

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	24	123	$8,158
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	14	$15,833
2019	14	74	$16,147
2020	19	138	$233,828
2021	40	247	$522,776
2022	45	310	$673,928
2023	63	346	$1,361,669
2024	71	665	$3,554,719

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	21	21	$142
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	124	254	$116
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	53	188	$97
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	47	53	$77
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	70	138	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Brukinsa	Zanubrutinib	77	2,310	$1,022,907
Imbruvica	Ibrutinib	50	1,456	$975,456
Calquence	Acalabrutinib Maleate	63	1,890	$825,995
Venclexta	Venetoclax	35	1,050	$539,195
Eliquis	Apixaban	18	632	$12,066

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$72	Genentech USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	16	$17,240	BeiGene, Ltd.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Seo-Hyun Kim, M.D.?

Tedicare shows public-source Medicare data for Seo-Hyun Kim, M.D. (NPI 1710253992), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Seo-Hyun Kim, M.D. have ACO affiliation data?

Seo-Hyun Kim, M.D. is shown with ACO affiliation data for CVS Accountable Care Organization, Inc. (REACH, ACO ID D0061).

What billing organization is linked to Seo-Hyun Kim, M.D.?

Seo-Hyun Kim, M.D. is linked to RUSH UNIVERSITY MEDICAL GROUP (billing NPI 1093819542) in the available physician profile data.

Does Seo-Hyun Kim, M.D. have Open Payments data?

Seo-Hyun Kim, M.D. has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.